Zheng, R., Li, J., Zhang, H. (2026). Adebrelimab plus TACE and/or HAIC for primary liver cancer: A retrospective study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.296